ERI-ICP is a professional organization with some 100 founding members including many of the most prominent European researchers (and several Nobel laureates) working on integrated cellular pathology. The principal objective of ERI-ICP, a virtual research institute, is to promote cell biology research applied to major human diseases, including (but not limited to) neurodegenerative diseases, myopathies, mitochondriopathies, infectious diseases, cancer and pathological aging. ERI-ICP promotes the implementation and utilization of systems biology (or integrated biology) by establishing a continuum between fundamental, translational and clinical research. ERI-ICP strives for excellence, independence, leadership, diversity and flexibility. Throughout its work, ERI-ICP provides independent, authoritative and evidence-based advice to underpin policy for stimulating the implementation of systems biology applicable to the investigation, classification, diagnosis and therapeutic management of major human diseases.
ERI-ICP disseminates “official” (but ameliorable) methods and protocols applicable to integrated cellular pathology. ERI-ICP also participates in efforts of data integration, provides a web forum for researchers working in the area of systems biology applied to human disease, and organizes annual conferences. By the conjunction of these activities, ERI-ICP is able to set up the standards for data quality, for data exchange and storage that are crucial for systems biology, as applied to human disease.
Therefore, ERI-ICP serves as an instrument to crystallize and streamline all efforts within the European research area. The founding members of ERI-ICP have been selected among highly renowned scientists from all areas of disease-oriented fundamental and clinical research. The founding group is responsible for defining the overall objectives of the institute, addressing issues such as credibility of the institution, membership and governance. To steer the process, a ‘Governing Body’ consisting of a president, a vice- president, a secretary-general and five fellows representing all disciplines Europe-wide, will be established. To address issues as they arise, ad hoc taskforces will be organized amongst members of the Institute, specific to their area of expertise. Founding members of ERIICP can anticipate contributing to the preparation of position papers, interacting with EU and national institutions to facilitate proposals and the implementation of new policies that ensure that disease-oriented systems biology remain at the top of the European research agenda.

0
0
0
s2sdefault